LEARNING OBJECTIVES: After participating in this activity, learners should be better able to: ABSTRACT: The psychosis prodrome, or period of clinical and functional decline leading up to acute psychosis, offers a unique opportunity for identifying mechanisms of psychosis onset and for testing early-intervention strategies. We summarize major findings and emerging directions in prodromal research and provide recommendations for clinicians working with individuals suspected to be at high risk for psychosis. The past two decades of research have led to three major advances. First, tools and criteria have been developed that can reliably identify imminent risk for a psychotic disorder. Second, longitudinal clinical and psychobiological data from large multisite studies are strengthening individual risk assessment and offering insights into potential mechanisms of illness onset. Third, psychosocial and pharmacological interventions are demonstrating promise for delaying or preventing the onset of psychosis in help-seeking, high-risk individuals. The dynamic psychobiological processes implicated in both risk and onset of psychosis, including altered gene expression, cognitive dysfunction, inflammation, gray and white matter brain changes, and vulnerability-stress interactions suggest a wide range of potential treatment targets and strategies. The expansion of resources devoted to early intervention and prodromal research worldwide raises hope for investigating them. Future directions include identifying psychosis-specific risk and resilience factors in children, adolescents, and non-help-seeking community samples, improving study designs to test hypothesized mechanisms of change, and intervening with strategies that, in order to improve functional outcomes, better engage youth, address their environmental contexts, and focus on evidence-based neurodevelopmental targets. Prospective research on putatively prodromal samples has the potential to substantially reshape our understanding of mental illness and our efforts to combat it.
LEARNING OBJECTIVES: After participating in this activity, learners should be better able to: ABSTRACT: The psychosis prodrome, or period of clinical and functional decline leading up to acute psychosis, offers a unique opportunity for identifying mechanisms of psychosis onset and for testing early-intervention strategies. We summarize major findings and emerging directions in prodromal research and provide recommendations for clinicians working with individuals suspected to be at high risk for psychosis. The past two decades of research have led to three major advances. First, tools and criteria have been developed that can reliably identify imminent risk for a psychotic disorder. Second, longitudinal clinical and psychobiological data from large multisite studies are strengthening individual risk assessment and offering insights into potential mechanisms of illness onset. Third, psychosocial and pharmacological interventions are demonstrating promise for delaying or preventing the onset of psychosis in help-seeking, high-risk individuals. The dynamic psychobiological processes implicated in both risk and onset of psychosis, including altered gene expression, cognitive dysfunction, inflammation, gray and white matter brain changes, and vulnerability-stress interactions suggest a wide range of potential treatment targets and strategies. The expansion of resources devoted to early intervention and prodromal research worldwide raises hope for investigating them. Future directions include identifying psychosis-specific risk and resilience factors in children, adolescents, and non-help-seeking community samples, improving study designs to test hypothesized mechanisms of change, and intervening with strategies that, in order to improve functional outcomes, better engage youth, address their environmental contexts, and focus on evidence-based neurodevelopmental targets. Prospective research on putatively prodromal samples has the potential to substantially reshape our understanding of mental illness and our efforts to combat it.
Authors: Romina Mizrahi; Jean Addington; Pablo M Rusjan; Ivonne Suridjan; Alvina Ng; Isabelle Boileau; Jens C Pruessner; Gary Remington; Sylvain Houle; Alan A Wilson Journal: Biol Psychiatry Date: 2011-11-30 Impact factor: 13.382
Authors: P Tienari; L C Wynne; J Moring; I Lahti; M Naarala; A Sorri; K E Wahlberg; O Saarento; M Seitamaa; M Kaleva Journal: Br J Psychiatry Suppl Date: 1994-04
Authors: Patrick D McGorry; Barnaby Nelson; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Annette Thampi; Gregor E Berger; G Paul Amminger; Magenta B Simmons; Daniel Kelly; Grad Dip; Andrew D Thompson; Alison R Yung Journal: J Clin Psychiatry Date: 2012-11-27 Impact factor: 4.384
Authors: Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis Journal: Schizophr Res Date: 2009-01-12 Impact factor: 4.939
Authors: Pekka Tienari; Lyman C Wynne; Anneli Sorri; Ilpo Lahti; Kristian Läksy; Juha Moring; Mikko Naarala; Pentti Nieminen; Karl-Erik Wahlberg Journal: Br J Psychiatry Date: 2004-03 Impact factor: 9.319
Authors: M Friedman-Yakoobian; E M Parrish; A Thomas; R Lesser; A Gnong-Granato; S Eack; M S Keshavan Journal: Schizophr Res Date: 2019-02-05 Impact factor: 4.939
Authors: Kristen A Woodberry; Larry J Seidman; Caitlin Bryant; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods Journal: J Clin Child Adolesc Psychol Date: 2016-10-05
Authors: Kristen A Woodberry; Kate S Powers; Caitlin Bryant; Donna Downing; Mary B Verdi; Katherine M Elacqua; Audrey R L Reuman; Leda Kennedy; Daniel I Shapiro; Michelle L West; Debbie Huang; Francesca M Crump; Margaux M Grivel; Drew Blasco; Shaynna N Herrera; Cheryl M Corcoran; Larry J Seidman; Bruce G Link; William R McFarlane; Lawrence H Yang Journal: Schizophr Res Date: 2021-09-28 Impact factor: 4.662
Authors: Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman Journal: Schizophr Res Date: 2018-08-02 Impact factor: 4.939
Authors: Michelle S Friedman-Yakoobian; Michelle L West; Kristen A Woodberry; Keira E O'Donovan; Suzannah V Zimmet; Andréa Gnong-Granato; Anthony J Giuliano; Margaret E Guyer; Janine Rodenhiser-Hill; Matcheri S Keshavan; Larry J Seidman Journal: Harv Rev Psychiatry Date: 2018 Sep/Oct Impact factor: 3.732
Authors: Tyler M Moore; Monica E Calkins; Adon F G Rosen; Ellyn R Butler; Kosha Ruparel; Paolo Fusar-Poli; Nikolaos Koutsouleris; Philip McGuire; Tyrone D Cannon; Ruben C Gur; Raquel E Gur Journal: Psychol Med Date: 2021-01-12 Impact factor: 10.592
Authors: Kristen A Woodberry; Cole Chokran; Kelsey A Johnson; Keith H Nuechterlein; David J Miklowitz; Stephen V Faraone; Larry J Seidman Journal: Early Interv Psychiatry Date: 2020-04-01 Impact factor: 2.721